Since blood NGF levels can be raised in cardiovascular diseases, bladder cancer, and bladder nephrolithiasis, as well as some neurological diseases or diabetes, it appears that the most specific and sensitive method is assessment of urine NGF. This evidence concerns the gene NGF and urinary bladder carcinoma.